Ryan Pearson’s team will explore how engineered nanoparticles can safely retrain the immune system to reduce allergic airway inflammation.

Researchers are developing a novel therapy using safe, drug-free nanoparticles to aid the body in fighting sepsis more effectively.

New study sheds light on how disease progression and biomolecular corona affect nanoparticle-mediated immune activation.

Pharmaceutical scientist aims to foster continued collaborations and drive interdisciplinary research.

Five-year grant supports research on nanoparticles’ design on inflammatory responses

Award from the Maryland Industrial Partnerships (MIPS) program supports work to formulate Clofazimine for treatment of recurrent C. difficile infections.